Physician profile
Allison Mcgee
NPI 1467950659
$3,247.69
in general payments reported to CMS, 2019-2025
39 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $709 · 2023: $356 · 2024: $485 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,415.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.30 | 2021-2025 | |
| Novo Nordisk INC | $285.48 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $231.37 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $205.81 | 2022-2025 | |
| Amgen INC. | $181.93 | 2024-2025 | Evenity, Repatha, Prolia |
| Otsuka America Pharmaceutical, INC. | $145.52 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $138.46 | 2021-2025 | Spravato |
| Lilly USA, LLC | $134.64 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $115.88 | 2023-2025 | Cologuard Collection Kit |
| Kite Pharma, INC. | $104.49 | 2025 | Yescarta |
| Glaxosmithkline, LLC. | $103.73 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Antares Pharma, INC. | $77.41 | 2022-2024 | Xyosted |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.25 | 2021-2024 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $56.45 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.43 | 2022-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.